- Rapid Dose (DOSE) has signed a supplier agreement with a leading gas and convenience store retailer
- The company’s QuickStrip Sleep (melatonin) and QuickStrip Energy (caffeine) products will be available at 300 retail locations across Ontario beginning this October
- An additional 400 locations throughout the province will follow soon thereafter
- Rapid Dose Therapeutics is a Canadian biotechnology company revolutionizing drug delivery through its orally dissolvable QuickStrip product
- Rapid Dose (DOSE) was halted from trading at $0.09 per share on August 29, 2022, due to a delay in filing its annual financial statements and other required documents
Rapid Dose (DOSE) has signed a supplier agreement with a leading gas and convenience store retailer.
The company’s QuickStrip Sleep (melatonin) and QuickStrip Energy (caffeine) products will be available at 300 retail locations across Ontario beginning this October. Distribution to an additional 400 locations throughout the province will follow soon thereafter.
The agreement was signed on August 24, 2022, with the initial purchase order dated September 15, 2022.
“Gaining exposure of our QuickStrip-branded products in this prominent convenience retail chain is an excellent win for our team as it will help to quickly drive market awareness of our innovative offerings,” said Mark Upsdell, Rapid Dose’s CEO.
The company will be releasing updates about new distribution deals over the coming weeks.
Rapid Dose Therapeutics is a Canadian biotechnology company revolutionizing drug delivery. Its flagship QuickStrip product is a thin, orally dissolvable film that can be combined with active ingredients to quickly deliver them into the bloodstream.
Rapid Dose (DOSE) was halted from trading at $0.09 per share on August 29, 2022, due to a delay in filing its annual financial statements and other required documents.